Vita 34 records moderate upward trend in the second quarter – PharmiWeb.com
stemadminStem Cell BankingNo comments

DGAP-News: Vita 34 AG / Key word(s): Half Year Results/Half Year ReportVita 34 records moderate upward trend in the second quarter 30.08.2022 / 19:20 CET/CESTThe issuer is solely responsible for the content of this announcement. Vita 34 records moderate upward trend in the second quarter Leipzig, 30 August 2022 - Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84), the leading cell bank in Europe and the third largest in the world, was able to benefit from a moderate upward trend in the further course of the first half of the year after an overall weaker start to the year. Although overall business development still falls short of potential, the company anticipates an improvement in the situation in the second half of the year. As in the first quarter, revenues of EUR 32.1 million in the first six months were around three times as high as in the same period of the previous year (H1 2021: EUR 10.5 million) as a result of the merger with PBKM FamiCord. The reasons for the overall nevertheless restrained business development lie in a clearly perceptible decline in demand from new customers.

Read more
dental stem cell banking – National Dental Pulp Laboratory
stemadminStem Cell BankingNo comments

NDPL is a worldwide leader in cryogenics and dental stem cell banking, and provides an easy, affordable way to save the valuable stem cells in your teeth. Search. 774-843-2984; Contact; ... Banking your dental stem cells with NDPL will preserve your familys opportunity to access to the most cutting-edge dental and medical advancements that ..

Read more
Global Cell Banking Outsourcing Market to Grow at a CAGR of ~18% during 2022-2031; Market to Expand Owing to the Development of Advanced Cell…
stemadminStem Cell BankingNo comments

New York, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Kenneth Research has published a detailed market report on Global Cell Banking Outsourcing Market for the forecast period, i.e., 2022 2031, which includes the following factors: Global Cell Banking Outsourcing Market Size: The global cell banking outsourcing market generated the revenue of approximately USD 7200.1 million in the year 2021 and is expected to garner a significant revenue by the end of 2031, growing at a CAGR of ~18% over the forecast period, i.e., 2022 2031. The growth of the market can primarily be attributed to the development of advanced preservation techniques for cells, and increasing adoption of regenerative cell therapies for the treatment of chronic diseases such as cancer. Additionally, factors such as growing demand for gene therapy, and increasing worldwide prevalence of cancer are expected to drive the market growth. According to the World Health Organization, nearly 10 million people died of cancer across the globe in 2020

Read more
Stem cell therapy to be used in treatment of long COVID by Panacell Biotech – Labiotech.eu
stemadminStem Cell BankingNo comments

A South Korean biotech company says it will use natural killer (NK) cells, exosomes and brown adipose-derived stem cells (ADSC) as treatment of long COVID. NK cells are a type of immune cell that have granules or small particles that can kill tumor cells or those infected with a virus. Panacell Biotech said they can be used to treat those with terminal illness as well as those with long COVID or post COVID-19 conditions. The company isSouth Koreasresearch institute specializing in advanced regenerative medical cell therapy using adipose-derived stem cells (ADSC). It announced today (August10)that it will soon conduct those cells toxicity tests through clinical trials and laboratory animals.

Read more
Building a healthtech industry in Europe to serve patients – Labiotech.eu
stemadminStem Cell BankingNo comments

By Maryvonne Hiance, president of HealthTech For Care; and Christian Pierret, Former Minister Delegate for Industry The HealthTech For Care endowment fund, launched by France Biotech is designed to support and promote access to care for all and, more specifically, to new medical technologies and drugs. Europe is just emerging from a health crisis that has tested its healthcare system and exposed its lack of autonomy in terms of R&D and health data management, as well as its weaknesses in terms of biomanufacturing.

Read more
Cell & Gene Therapy Manufacturing Services Market Research Report : With Healthy CAGR 7.8% : Will Reach USD 56.7 Billion by 2028 – Digital Journal
stemadminStem Cell BankingNo comments

Cell & Gene Therapy Manufacturing Services Market Size, Share & Segment by Type (Gene Therapy Manufacturing, Cell Therapy Manufacturing), By Scale Type (Commercial Scale Manufacturing, Pre-commercial/ R&D Scale Manufacturing), By Mode type (In-house Manufacturing, Contract Manufacturing), By Workflow type (Cell Processing, Fill & Finish Operations, Vector Production, Analytical And Quality Testing, Cell Banking, Process Development, Raw Material Testing, Others), by Regions and Global Forecast 2022-2028 This press release was orginally distributed by SBWire Pune, Maharashtra (SBWIRE) 08/02/2022 Market Overview, Definition, and StatisticsCell and gene therapy manufacturing is a difficult, drawn-out procedure that needs to adhere to stringent rules in order to meet compliance standards. This may potentially cause a delay in how quickly patients receive medicines that could save their lives

Read more
Stem Cell Banking Market Size to Accelerate at a Rapid CAGR of 16.1% from 2022 to 2029 – Digital Journal
stemadminStem Cell BankingNo comments

The consistent Stem Cell Banking Market report can be referred efficiently by both established and new players in the Healthcare industry for absolute understanding of the market. It covers various parameters that range from latest trends, market segmentation, new market entry, industry forecasting, target market analysis, future directions, opportunity identification, strategic analysis, insights to innovation

Read more
Global Stem Cell Banking Outsourcing Market 2022 Trend Analysis, Growth Status, Revenue Expectation to 2028 This Is Ardee – This Is Ardee
stemadminStem Cell BankingNo comments

The Global Stem Cell Banking Outsourcing Market report by the MarketsandResearch.biz is a detailed analysis of the market based on the drivers, restraints, opportunities, and challenges. The studies the strategies of each company dominating the Stem Cell Banking Outsourcing market along with vital factors such as market gross margin, product specifications, price, revenue, markets served, production, main business, applications, introduction, areas served, and production sites

Read more

Theme: Illdy.